Combination PancVAX neo-epitope vaccine with anti-CTLA-4 and anti-PD-1 antibodies enhances infiltration of cytotoxic T cells and mitigates T cell exhaustion in a murine model of pancreatic ductal adenocarcinoma

被引：0
|
作者：
Mitchell, Jacob T.
Huff, Amanda
Davis-Marcisak, Emily
Chen, Fangluo
Armstrong, Todd D.
Kagohara, Luciane T.
Leatherman, James
Wang, Rulin
Yegnasubramanian, Srinivasan
Jaffee, Elizabeth M.
Fertig, Elana J.
Zaidi, Neeha
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5076
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5076
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A differential ligand- receptor network inference method to identify alterations in communication between myeloid cells and CD8 T cells in response to PancVAX neo-epitope peptide vaccine, anti-CTLA-4 and anti-PD-1 antibodies in a murine model of pancreatic ductal adenocarcinoma
    Mitchell, Jacob T.
    Deshpande, Atul
    Huff, Amanda L.
    Cherry, Chris
    Nagaraj, Sushma
    Krishnan, Kavita
    Lvovs, Dmitrijs
    Elisseeff, Jennifer H.
    Jaffee, Elizabeth M.
    Zaidi, Neeha
    Fertig, Elana J.
    CANCER RESEARCH, 2024, 84 (06)
  • [2] TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy
    Liu, Heng-Jia
    Lizotte, Patrick H.
    Du, Heng
    Speranza, Maria C.
    Lam, Hilaire C.
    Vaughan, Spencer
    Alesi, Nicola
    Wong, Kwok-Kin
    Freeman, Gordon J.
    Sharpe, Arlene H.
    Henske, Elizabeth P.
    JCI INSIGHT, 2018, 3 (08):
  • [3] An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model
    Hideto Ueki
    Koichi Kitagawa
    Mako Kato
    Shihoko Yanase
    Yasuyoshi Okamura
    Yukari Bando
    Takuto Hara
    Tomoaki Terakawa
    Junya Furukawa
    Yuzo Nakano
    Masato Fujisawa
    Toshiro Shirakawa
    Scientific Reports, 13
  • [4] An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model
    Ueki, Hideto
    Kitagawa, Koichi
    Kato, Mako
    Yanase, Shihoko
    Okamura, Yasuyoshi
    Bando, Yukari
    Hara, Takuto
    Terakawa, Tomoaki
    Furukawa, Junya
    Nakano, Yuzo
    Fujisawa, Masato
    Shirakawa, Toshiro
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [5] Anti-CTLA-4 generates memory T-cells with greater expansion and functionality than anti-PD-1
    Mok, Stephen
    Anang, Nana-Ama A. S.
    Mancuso, James J.
    Allison, James P.
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Anti-CTLA-4 generates memory T-cells with greater expansion and functionality than anti-PD-1
    Mok, Stephen
    Liu, Huey
    Anang, Nana-Ama A. S.
    Mancuso, James J.
    Cobanoglu, Didem Agac
    Allison, James P.
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Anti-CTLA-4 generates memory T-cell with greater expansion and functionality than anti-PD-1
    Mok, Stephen
    Liu, Huey
    Anang, Nana-Ama A. S.
    Mancuso, James J.
    Cobanoglu, Didem Agac
    Allison, James P.
    CANCER IMMUNOLOGY RESEARCH, 2023, 11 (12)
  • [8] Effects of anti-ctla-4 and anti-pd-1 on memory T-cell differentiation and resistance to tumor relapse
    Mok, Stephen
    Duffy, Colm R.
    Allison, James P.
    CANCER RESEARCH, 2017, 77
  • [9] Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse
    Mok, Stephen
    Duffy, Colm R.
    Anang, Nana-Ama A. S.
    Allison, James P.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [10] Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse
    Mok, Stephen
    Duffy, Colm R.
    Allison, James P.
    CANCER RESEARCH, 2018, 78 (13)
12345